Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Robotic Assessments of Hand Function in Patients With Parkinson's Disease

NCT05245955 · Swiss Federal Institute of Technology · Updated 13 Sept 2023

What is being tested
Assessments of the hand sensory function with the ReHapticKnob
For
Parkinson Disease
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 35 years to 80 years. About 20 people. The full rules are on the registry page.
Where
Switzerland
When
Starts or started 14 March 2022, ends 12 Sept 2023. Registered 18 Feb 2022.
Results
None posted yet.

In the researchers' words

It has been shown that patients with Parkinson's disease (PD) have impaired kinaesthesia and haptic perception of the upper limbs. In PD patients, these impairments might be involved in the development of hypometria or bradykinesia and may play a role in postural deficits, thereby significantly contributing to the overall disability level. Dedicated conventional or robot-assisted training might improve sensory-motor function in PD patients. In order to provide efficient robot-assisted therapy, robotic devices have to be able to tailor the therapy difficulty to the individual impairment profile of each patient. For difficulty adaptation in robot-assisted therapy, it is important to assess the impairment profiles with the same robotic platform that would be used for therapy, therefore minimizing costs or potential errors coming from the use of different devices. However, up to now, little emphasis has been placed on providing sensory-motor robot-assisted therapy for the upper limbs to persons with PD based on their individual level of impairment. The aim of this study is therefore to evaluate if the assessments of sensory-motor hand function implemented on a robotic device for hand rehabilitation, i.e. the ReHapticKnob, are suitable to measure the impairments of kinaesthesia and haptic perception observed in subjects with Parkinson's disease. If the assessments implemented in…
ClinicalTrials.gov, NCT05245955

Sites

  • Clinica Hildebrand, Centro di Rehabilitazione BrissagoBrissago, Switzerland